• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Oridion Systems Ltd.

Medtronic launches opioid-induced respiratory depression study

May 31, 2017 By Brad Perriello

Medtronic (NYSE:MDT) said today that it’s starting a large study on the effect of pulse oximetry and capnography in opioid-induced respiratory depression, using its Capnostream device. The 1,650-patient Prodigy study aims to create a tool to score the risk of OIRD in patients being treated with opioids for pain, using Capnostream’s continuous pulse oximetry and capnography monitoring […]

Filed Under: Clinical Trials, Pharmaceutical, Respiratory Tagged With: Covidien, Medtronic, Oridion Systems Ltd.

Covidien closes $300 million Oridion deal

June 26, 2012 By MassDevice staff Leave a Comment

Covidien logo
Oridion Systems logo

As expected, Covidien (NYSE:COV) closed its $300 million merger of Oridion Systems, an Israeli maker of pulse oximetry products.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Covidien, Oridion Systems Ltd.

MassDevice.com +3 | The top 3 med-tech stories for April 5, 2012.

April 5, 2012 By MassDevice staff Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Filed Under: Mergers & Acquisitions, News Well, Recalls, Wall Street Beat Tagged With: Covidien, Oridion Systems Ltd., Philips, Thoratec Corp.

Oridion shares spike 70% on Covidien merger news

April 5, 2012 By MassDevice staff Leave a Comment

Covidien logo
Oridion Systems logo

Filed Under: Mergers & Acquisitions, News Well, Respiratory, Wall Street Beat Tagged With: Covidien, Oridion Systems Ltd.

Federal Circuit reverses course, reinstates Marine Polymer’s $29M win over Hemcon | Legal News

March 16, 2012 By MassDevice staff Leave a Comment

Marine Polymer, HemCon

A sharply split federal appeals court reversed course and reinstated a $29.4 million win for Marine Polymer Technologies in its wound dressing patent spat with HemCon Medical Technologies.

The U.S. Court of Appeals for the Federal Circuit, in an en banc decision joined in full by 5 of 9 judges on the panel, ruled that the "intervening rights" of a company accused of patent infringement are only valid when patent claim language is changed during re-examination.

Filed Under: Legal News, News Well, Patent Infringement Tagged With: Acacia Research Corp., HemCon Medical Technologies Inc., Legal Roundup, Marine Polymer Technologies Inc., Oridion Systems Ltd., Smith & Nephew, Triad Group

Elekta’s Q3 sales spike, earnings soar | Earnings Roundup

March 7, 2012 By MassDevice staff Leave a Comment

MassDevice.com Earnings Roundup

 Elekta’s Q3 sales spike, earnings soar

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: CAS Medical Systems Inc., DGT Holdings, Elekta, Essilor International, Imris Inc., Iridex Corp., Oridion Systems Ltd., Q4, Stereotaxis

Thoratec settles Oracle beef | Wall Street Beat

January 26, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Thoratec Corp. (NSDQ:THOR) said it reached an agreement with one of its major institutional shareholders, Oracle Investment Management, over whether or not the heart pump maker should hire an investment bank to find a buyer.

Greenwich, Conn.-based Oracle, which holds a 5.2% stake in the heart pump maker, recommended that Thoratec retain an investment bank to explore strategic alternatives, including sale to a larger company.

Filed Under: Cosmetic/Aesthetic, Legal News, News Well, Recalls, Respiratory, Spine, Structural Heart, Surgical Robotics, Wall Street Beat Tagged With: AngioDynamics, Hologic, Nuvasive, Oridion Systems Ltd., stjudemedical, The Cooper Cos., Thoratec Corp.

Oridion can resume importing most of its medical devices into the U.S.

January 20, 2012 By MassDevice staff Leave a Comment

Oridion Systems Ltd. (PINK:ORDNF) can resume importing medical devices into the U.S., after the FDA reduced its ban on the company to include just 2 of its product lines.

On Dec. 20, 2011, the Israeli med-tech maker was barred by the FDA from importing any medical devices into the U.S, after the agency said the company failed to fix violations at its Jerusalem manufacturing facility.

Filed Under: Food & Drug Administration (FDA), News Well, Pediatrics Tagged With: Oridion Systems Ltd., Philips

MassDevice.com +7 | Synthes goes after Stryker, Oridion shares drop after import ban, FDA aims at reused med-tech, Accuray and Siemens amend ties, SNN spins out biologics unit, FDA releases December recalls and St. Jude expands in Plymouth

January 7, 2012 By MassDevice staff Leave a Comment

Plus Seven

Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.

Filed Under: Food & Drug Administration (FDA), Legal News, Mergers & Acquisitions, News Well, Recalls, Wall Street Beat Tagged With: Accuray Inc., depuysynthes, Essex Woodlands Health Ventures, Exports, Oridion Systems Ltd., Plus 7, Siemens, Smith & Nephew, stjudemedical, Stryker

MassDevice.com +3 | U-Wisc. chair under fire for MDT ties, Texas medical supplier gets 12 years, FDA bans Oridion-shares fall 40%

January 2, 2012 By MassDevice staff Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3. And Happy New Year from the MassDevice team!

Filed Under: Food & Drug Administration (FDA), Legal News, News Well Tagged With: Centers for Medicare and Medicaid Services (CMS), Exports, Oridion Systems Ltd.

FDA bans Oridion imports, share prices dive 40%

January 2, 2012 By MassDevice staff Leave a Comment

The FDA banned Oridion Systems Ltd. (PINK:ORDNF) from importing any medical devices into the U.S., after the Israeli med-tech maker failed to fix violations at its Jerusalem manufacturing facility.

Shares of Oridion fell 39% on news of the ban, from $11.00 to $6.65 at market opening Dec. 27.

Filed Under: Food & Drug Administration (FDA), News Well, Recalls, Respiratory Tagged With: CareFusion Corp., Exports, Oridion Systems Ltd., Smiths Medical

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy